$ tb500 --contact
Contact the Legit TB-500 editorial desk
Corrections, citation questions, and editorial inquiries. Not a sales, clinical, or prescription channel.
What to write to us about
This is an editorial contact channel for the TB-500 digest. The most useful messages flag a citation that should be corrected, a study we missed, or a place where the fragment-versus-full-length-protein distinction could be sharper. We read the literature for a living and we would rather fix an error than defend one, so corrections are welcome and acted on.
What this channel is not: it is not a way to buy, order, or source any substance, and it is not a clinical or prescribing service. We do not sell, supply, or recommend TB-500, and we cannot advise on personal use, dosing, or access to compounded preparations. Questions of that kind belong with an appropriately licensed prescriber, not with an editorial desk.
Using the form
Use the form below for corrections and editorial inquiries. A short, specific note — the page, the claim, and the source you are referencing — gets the fastest and most accurate reply. We do not collect health information, and we ask that you not send any; this is a digest of published research, and the conversation we can have is about that record and its sources, nothing more. For the regulatory standing of the compound, the legal-status page is the place to start, and the references page lists every source we cite.